根据ESI于2025年1月发布的数据，我校高被引论文（Highly Cited Papers）527篇，热点论文（Hot Papers）18篇，见附件：2025年1月南方医科大学高被引论文及热点论文简表。详情如下。
从学科角度看，在527篇高被引论文中，临床医学最多（258篇），占比48.96%，药理学与毒理学43篇（8.16%）紧跟其后。
|
序号 |
高被引论文 Research Field |
2025.1 |
2024.11 |
||
|
论文数 |
占比 |
论文数 |
占比 |
||
|
CLINICAL MEDICINE |
258 |
48.96% |
248 |
49.11% |
|
|
2 |
MOLECULAR BIOLOGY & GENETICS |
39 |
7.40% |
46 |
9.11% |
|
3 |
BIOLOGY & BIOCHEMISTRY |
37 |
7.02% |
37 |
7.33% |
|
4 |
PHARMACOLOGY & TOXICOLOGY |
43 |
8.16% |
39 |
7.72% |
|
5 |
MATERIALS SCIENCE |
36 |
6.83% |
30 |
5.94% |
|
6 |
NEUROSCIENCE & BEHAVIOR |
16 |
3.04% |
15 |
2.97% |
|
7 |
ENGINEERING |
11 |
2.09% |
10 |
1.98% |
|
8 |
MICROBIOLOGY |
13 |
2.47% |
11 |
2.18% |
|
9 |
CHEMISTRY |
8 |
1.52% |
8 |
1.58% |
|
10 |
PHYSICS |
13 |
2.47% |
11 |
2.18% |
|
11 |
PSYCHIATRY/PSYCHOLOGY |
13 |
2.47% |
12 |
2.38% |
|
12 |
IMMUNOLOGY |
11 |
2.09% |
11 |
2.18% |
|
13 |
SOCIAL SCIENCES, GENERAL |
6 |
2.33% |
5 |
0.99% |
|
14 |
COMPUTER SCIENCE |
8 |
1.52% |
9 |
1.78% |
|
15 |
GEOSCIENCES |
1 |
0.19% |
1 |
0.20% |
|
16 |
AGRICULTURAL SCIENCES |
6 |
1.14% |
3 |
0.59% |
|
17 |
MULTIDISCIPLINARY |
1 |
0.19% |
1 |
0.20% |
|
18 |
ENVIRONMENT/ECOLOGY |
5 |
0.95% |
6 |
1.19% |
|
19 |
MATHEMATICS |
1 |
0.19% |
2 |
0.40% |
|
20 |
PLANT & ANIMAL SCIENCE |
1 |
0.19% |
0 |
0 |
|
21 |
合计 |
527 |
100.00% |
505 |
100.00% |
|
序号 |
2025年1月我校18篇热点论文 标题 |
来源期刊 |
DOI |
Research Field |
Times Cited |
|
1 |
MINIMAL INFORMATION FOR STUDIES OF EXTRACELLULAR VESICLES (MISEV2023): FROM BASIC TO ADVANCED APPROACHES |
JOURNAL OF EXTRACELLULAR VESICLES 13 (2): - FEB 2024 |
10.1002/jev2.12404 |
BIOLOGY & BIOCHEMISTRY |
428 |
|
2 |
TRIAL OF ENDOVASCULAR THERAPY FOR ACUTE ISCHEMIC STROKE WITH LARGE INFARCT |
NEW ENGLAND JOURNAL OF MEDICINE 388 (14): 1272-1283 APR 6 2023 |
10.1056/NEJMoa2213379 |
CLINICAL MEDICINE |
322 |
|
3 |
ASSOCIATION BETWEEN GUT MICROBIOTA AND PREECLAMPSIA-ECLAMPSIA: A TWO-SAMPLE MENDELIAN RANDOMIZATION STUDY |
BMC MEDICINE 20 (1): - NOV 15 2022 |
10.1186/s12916-022-02657-x |
CLINICAL MEDICINE |
204 |
|
4 |
ESTIMATED BURDEN OF STROKE IN CHINA IN 2020 |
JAMA NETWORK OPEN 6 (3): - MAR 2023 |
10.1001/jamanetworkopen.2023.1455 |
CLINICAL MEDICINE |
194 |
|
5 |
CAMRELIZUMAB PLUS RIVOCERANIB VERSUS SORAFENIB AS FIRST-LINE THERAPY FOR UNRESECTABLE HEPATOCELLULAR CARCINOMA (CARES-310): A RANDOMISED, OPEN-LABEL, INTERNATIONAL PHASE 3 STUDY |
LANCET 402 (10408): 1133-1146 SEP 30 2023 |
10.1016/S0140-6736(23)00961-3 |
CLINICAL MEDICINE |
175 |
|
6 |
OVERALL SURVIVAL WITH OSIMERTINIB IN RESECTED <I>EGFR</I>-MUTATED NSCLC |
NEW ENGLAND JOURNAL OF MEDICINE 389 (2): 137-147 JUL 13 2023 |
10.1056/NEJMoa2304594 |
CLINICAL MEDICINE |
169 |
|
7 |
REPRESSION OF THE ANTIPORTER SLC7A11/GLUTATHIONE/GLUTATHIONE PEROXIDASE 4 AXIS DRIVES FERROPTOSIS OF VASCULAR SMOOTH MUSCLE CELLS TO FACILITATE VASCULAR CALCIFICATION |
KIDNEY INTERNATIONAL 102 (6): 1259-1275 DEC 2022 |
10.1016/j.kint.2022.07.034 |
CLINICAL MEDICINE |
123 |
|
8 |
PREVALENCE OF CHRONIC KIDNEY DISEASE IN CHINA RESULTS FROM THE SIXTH CHINA CHRONIC DISEASE AND RISK FACTOR SURVEILLANCE |
JAMA INTERNAL MEDICINE 183 (4): 298-310 APR 2023 |
10.1001/jamainternmed.2022.6817 |
CLINICAL MEDICINE |
89 |
|
9 |
BIOMIMETIC NATURAL BIOMATERIALS FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE: NEW BIOSYNTHESIS METHODS, RECENT ADVANCES, AND EMERGING APPLICATIONS |
MILITARY MEDICAL RESEARCH 10 (1): - MAR 28 2023 |
10.1186/s40779-023-00448-w |
CLINICAL MEDICINE |
87 |
|
10 |
EXOSOMAL LOC85009 INHIBITS DOCETAXEL RESISTANCE IN LUNG ADENOCARCINOMA THROUGH REGULATING ATG5-INDUCED AUTOPHAGY |
DRUG RESISTANCE UPDATES 67: - MAR 2023 |
10.1016/j.drup.2022.100915 |
PHARMACOLOGY & TOXICOLOGY |
62 |
|
11 |
AGGREGATION-INDUCED EMISSION-BASED MACROPHAGE-LIKE NANOPARTICLES FOR TARGETED PHOTOTHERMAL THERAPY AND VIRUS TRANSMISSION BLOCKAGE IN MONKEYPOX |
ADVANCED MATERIALS 36 (9): - MAR 1 2024 |
10.1002/adma.202305378 |
MATERIALS SCIENCE |
62 |
|
12 |
ALECTINIB IN RESECTED <I>ALK</I>-POSITIVE NON-SMALL-CELL LUNG CANCER |
NEW ENGLAND JOURNAL OF MEDICINE 390 (14): 1265-1276 APR 11 2024 |
10.1056/NEJMoa2310532 |
CLINICAL MEDICINE |
44 |
|
13 |
THE CHINESE SOCIETY OF CLINICAL ONCOLOGY (CSCO): CLINICAL GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF GASTRIC CANCER, 2023 |
CANCER COMMUNICATIONS : - DEC 31 2023 |
10.1002/cac2.12516 |
CLINICAL MEDICINE |
28 |
|
14 |
IN VIVO LIVER FUNCTION RESERVE ASSESSMENTS IN ALCOHOLIC LIVER DISEASE BY SCALABLE PHOTOACOUSTIC IMAGING |
PHOTOACOUSTICS 34: - DEC 2023 |
10.1016/j.pacs.2023.100569 |
ENGINEERING |
28 |
|
15 |
PULMONARY HYPERTENSION |
NATURE REVIEWS DISEASE PRIMERS 10 (1): - JAN 4 2024 |
10.1038/s41572-023-00486-7 |
CLINICAL MEDICINE |
24 |
|
16 |
MODULATING EXTRACELLULAR MATRIX STIFFNESS: A STRATEGIC APPROACH TO BOOST CANCER IMMUNOTHERAPY |
CELL DEATH & DISEASE 15 (5): - MAY 1 2024 |
10.1038/s41419-024-06697-4 |
MOLECULAR BIOLOGY & GENETICS |
20 |
|
17 |
COPPER AND COPPER COMPLEXES IN TUMOR THERAPY |
CHEMMEDCHEM 19 (11): - JUN 3 2024 |
10.1002/cmdc.202400060 |
PHARMACOLOGY & TOXICOLOGY |
15 |
|
18 |
USING CLUSTERPROFILER TO CHARACTERIZE MULTIOMICS DATA |
NATURE PROTOCOLS 19 (11): - NOV 2024 |
10.1038/s41596-024-01020-z |
BIOLOGY & BIOCHEMISTRY |
7 |
